Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE
Accepted 2024-12-17 00:00:00 ET · period of report 2024-12-14 · accession 0001801170-24-000248 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-12-17 | 2024-12-14+ | CLOV | Reynoso Jamie L. | CEO, Medicare Advantage | F - Tax | $3.11 | -21.3K | 3.33M | -0.6% | -$66.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-12-14 | F | D | 12,567 | $3.11 | 3,341,236 | D | — | — | (F1) Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 14, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date. |
| 2 | Common | Class A Common Stock | 2024-12-15 | F | D | 8,691 | $3.11 | 3,332,545 | D | — | — | (F2) Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 15, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date. |